Richard Barry bought $78k of FLNA
President & CEO at CASSAVA SCIENCES INC. 93,091 shares at an average of $0.84, traded Sep 28, 2026, filed Sep 30, 2026.
Score components
- +25RoleCEO
- +9Trade size$78k at market
- +3Relative to holdingsHoldings up 10%
- +8Price context82% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-26-031597, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 28, 2026 | POpen-market purchase Common Stockindirect: By Trust | +93,091 | $0.84 | $78k | 1,031,151 | 12 d ago |
Related signals
Other insiders at CASSAVA SCIENCES INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 58Moderate | FLNAbuy CASSAVA SCIENCES INC | Richard Barry President & CEO | $278k 306,813 shares | +30% | |
| 39Weak | CASSAVA SCIENCES INC | Robert Eugene Anderson Jr director | $25k 8,600 shares | - | |
| 65Notable | CASSAVA SCIENCES INC | Richard Barry President & CEO | $414k 150,000 shares | +19% | |
| 61Notable | CASSAVA SCIENCES INC | Richard Barry President & CEO | $202k 73,385 shares | +10% | |
| 50Moderate | CASSAVA SCIENCES INC | Robert Christopher Cook Chief Operating & Legal Office | $40k 13,725 shares | - | |
| 46Moderate | CASSAVA SCIENCES INC | Richard Barry President & CEO | $16k 7,172 shares | +1% | |
| 69Notable | CASSAVA SCIENCES INC | Richard Barry President & CEO | $535k 237,941 shares | +51% | |
| 48Moderate | CASSAVA SCIENCES INC | Eric Schoen Chief Financial Officer | $238k 61,800 shares | -3090% | |
| 43Moderate | CASSAVA SCIENCES INC | James William Kupiec Chief Medical Officer | $15k 4,000 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.